Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Solmi

Showing results (201-210 of 581) with videos related to

Pageof 59
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 2, 2026
Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, CanadaDaniel T Myran, Maya Gibb, Michael Pugliese, et al.
International Review of Psychiatry (Abingdon, England)|July 7, 2017
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventionsMichele Fornaro, Marco Solmi, Nicola Veronese, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effectsMarco Solmi, Michele Fornaro, Edoardo G Ostinelli, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|November 13, 2020
Hippocampal volumes in anorexia nervosa at different stages of the disorderEnrico Collantoni, Elena Tenconi, Marco Solmi, et al.
Neuroscience and Biobehavioral Reviews|March 18, 2022
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trendsMichel Sabe, Toby Pillinger, Stefan Kaiser, et al.
Maturitas|July 28, 2018
Pain is not associated with cognitive decline in older adults: A four-year longitudinal studyNicola Veronese, Ai Koyanagi, Marco Solmi, et al.
Journal of Affective Disorders|April 10, 2017
Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North AmericaNicola Veronese, Brendon Stubbs, Marco Solmi, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
First evidence of a general disease ("d") factor, a common factor underlying physical and mental illnessValerie Brandt, Yuning Zhang, Hannah Carr, et al.
Current Pharmaceutical Design|September 28, 2016
Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 DiabetesAnastasiya Slyepchenko, Michael Maes, Rodrigo Machado-Vieira, et al.
Journal of Affective Disorders|December 20, 2025
The Ottawa sunglasses at night study: A randomized controlled trial of blue-blocking glasses for maniaJess G Fiedorowicz, Eric Mikhail, Marco Solmi, et al.
Pageof 59

Showing results (201-210 of 581) with videos related to

Sort By:
Pageof 59
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 2, 2026
Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, CanadaDaniel T Myran, Maya Gibb, Michael Pugliese, et al.
International Review of Psychiatry (Abingdon, England)|July 7, 2017
The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventionsMichele Fornaro, Marco Solmi, Nicola Veronese, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effectsMarco Solmi, Michele Fornaro, Edoardo G Ostinelli, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|November 13, 2020
Hippocampal volumes in anorexia nervosa at different stages of the disorderEnrico Collantoni, Elena Tenconi, Marco Solmi, et al.
Neuroscience and Biobehavioral Reviews|March 18, 2022
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trendsMichel Sabe, Toby Pillinger, Stefan Kaiser, et al.
Maturitas|July 28, 2018
Pain is not associated with cognitive decline in older adults: A four-year longitudinal studyNicola Veronese, Ai Koyanagi, Marco Solmi, et al.
Journal of Affective Disorders|April 10, 2017
Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North AmericaNicola Veronese, Brendon Stubbs, Marco Solmi, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
First evidence of a general disease ("d") factor, a common factor underlying physical and mental illnessValerie Brandt, Yuning Zhang, Hannah Carr, et al.
Current Pharmaceutical Design|September 28, 2016
Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 DiabetesAnastasiya Slyepchenko, Michael Maes, Rodrigo Machado-Vieira, et al.
Journal of Affective Disorders|December 20, 2025
The Ottawa sunglasses at night study: A randomized controlled trial of blue-blocking glasses for maniaJess G Fiedorowicz, Eric Mikhail, Marco Solmi, et al.
Pageof 59